Renaissance Capital LLC Adaptive Biotechnologies Corp Transaction History

Renaissance Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$10.12 - $28.9 $448,953 - $1.28 Million	-44,363 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$25.17 - $36.85 $195,898 - $286,803	-7,783 Reduced 14.93%	44,363 $1.25 Million
Q3 2021 Feb 01, 2022	SELL	$30.02 - $39.87 $2.22 Million - $2.95 Million	-74,065 Reduced 58.68%	52,146 $1.77 Million
Q2 2021 Feb 01, 2022	BUY	$32.22 - $44.59 $605,284 - $837,667	18,786 Added 17.49%	126,211 $5.16 Million
Q1 2021 Feb 01, 2022	SELL	$37.26 - $67.74 $1.31 Million - $2.38 Million	-35,068 Reduced 24.61%	107,425 $4.33 Million
Q4 2020 Feb 01, 2022	BUY	$45.01 - $65.47 $6.41 Million - $9.33 Million	142,493 New	142,493 $8.43 Million

206

142M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.15B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.